17,956 women studied to sharpen cancer detection after menopause
NCT ID NCT03382145
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study reviewed the medical records of nearly 18,000 women who visited a special one-stop clinic for postmenopausal bleeding. The goal was to see how well ultrasound and other tests predict cancer or other serious conditions. By analyzing these past cases, researchers hope to create better guidelines for diagnosing and managing postmenopausal bleeding in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this review could help doctors better identify which women with postmenopausal bleeding are at higher risk for cancer, leading to faster and more targeted care.
- What could go wrong
- This is a retrospective review of existing records, not a controlled trial. It can show patterns but cannot prove that any specific test or approach improves outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTMENOPAUSAL BLEEDING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Chinese University of Hong Kong
Hong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a reusable device match the standard for uterine biopsy?
- Can a camera inside the womb replace the need for a biopsy?
- Which cervical prep eases hysteroscopy for postmenopausal women?
- New DNA test could spot uterine cancer from a urine sample
- Which biopsy method is better for diagnosing uterine bleeding?